Question · asked by 1 review
Antihypertensive drug class vs placebo: Calcium channel blocker (any dose) Mean duration of 3 weeks
- Population
- children (from 1 to 18 years of age) with hypertension from primary or secondary causes
- Intervention
- Antihypertensive drug class
- Comparison
- placebo
- Outcome
- Calcium channel blocker (any dose) Mean duration of 3 weeks
What each review found
Current versions onlyNo studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Antihypertensive drug class vs placebo Calcium channel blocker (any dose) Mean duration of 3 weeks · children (from 1 to 18 years of age) with hypertension from primary or secondary causes Pharmacological interventions for hypertension in children (2014) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 133 participants | Very low |
Antihypertensive drug class vs placebo Calcium channel blocker (any dose) Mean duration of 3 weeks · children (from 1 to 18 years of age) with hypertension from primary or secondary causes Pharmacological interventions for hypertension in children (2014) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 133 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Pharmacological interventions for hypertension in children 2014 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.